| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |